Rationally designed peptide-conjugated gold/platinum nanosystem with active tumor-targeting for enhancing tumor photothermal-immunotherapy.

Abstract

Because of the tumor heterogeneity, poor therapeutic outcome is obtained while the conventional treatments, such as surgery, radiotherapy, or chemotherapy are utilized alone. Herein, combinational therapy strategies have been introduced to solve this problem. Photothermal therapy (PTT) as a non-invasive thermal therapeutic manner has attracting enormous attentions not only for the effective inhibition in primary tumors, but also for producing tumor-associated antigens from ablated tumor cell residues which exhibit the feasibility to enhance the therapeutic outcome of immunotherapy. Here, we report the construction and application of Au@Pt-based nanosystem with rationally designed peptide (LyP-1-PLGVRG-DPPA-1, LMDP) conjugation for cancer photothermal-immunotherapy. The obtained Au@Pt-LMDP nanosystem can serve as a matrix metalloproteinase (MMP) activated tumor targeting agents for effective photothermal therapy together with immune checkpoint blockade immunotherapy by the on-demand release of a D-peptide antagonist of programmed cell death-ligand 1 (PD-L1). The PA imaging demonstrates its effective accumulation in the tumor region by the activated tumor targeting moiety derived from the LMDP. Moreover, in vivo anti-tumor studies reveal that Au@Pt-LMDP nanosystem can effectively eliminate primary tumors via PTT, and further stimulate the activation of cytotoxic T lymphocytes by PD-L1 immune checkpoint blockage, result in inhibiting the growth of distal tumors and alleviating tumor metastasis. The present study provides a promising strategy for the combination treatment of advanced cancer and obtains a valuable therapeutic outcome in tumor photothermal-immunotherapy.

• Authors: Qian Yang, Jinrong Peng, Kun Shi, Yao Xiao, Qingya Liu, Ruxia Han, Xiawei Wei, Zhiyong Qian
• Journal: Journal of controlled release : official journal of the Controlled Release Society (J Control Release) Vol. 308 Pg. 29-43 (08 28 2019) ISSN: 1873-4995 [Electronic] Netherlands
• PMID: 31252039 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: Copyright © 2019 Elsevier B.V. All rights reserved.

Chemical References

• Antigens, Neoplasm
• B7-H1 Antigen
• Peptides
• Platinum
• Gold

Topics

• Animals
• Antigens, Neoplasm (immunology)
• B7-H1 Antigen (antagonists & inhibitors)
• Breast Neoplasms (immunology, therapy)
• Cell Line, Tumor
• Combined Modality Therapy
• Female
• Gold (chemistry)
• Humans
• Immunotherapy (methods)
• Metal Nanoparticles
• Mice
• Mice, Inbred BALB C
• Peptides (chemistry)
• Phototherapy (methods)
• Platinum (chemistry)